Info@ThinkPinkRocks.com

Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS

Using next-generation sequencing (NGS) methods to analyze cell-free DNA in the blood of patients with myelodysplastic syndrome (MDS) yields more accurate results than the current standard approach of Sanger sequencing.

View post:
Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS

Share

Leave a Reply

Solve : *
17 − 6 =